Analyst Consensus ?
ConsensusBuy28 ratings
Bullish2382.1%
Neutral517.9%
Bearish00.0%
Apollo Global Management, Inc. · APO · FY2026 Q3 · Calendar Q4 2026
Apollo posts record Q3 earnings; maintains 2027 growth outlook
Record FRE and SRE, capital formation and origination support Apollo’s growth outlook, while funding costs, regulation, valuation pressure and AI-credit uncertainty temper the case.
Reported Before market openNYSEFinancial Services
$70.55B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $2.19
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $5.79B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-4.4%
Event window
SPY move
+0.4%
Same window
Abnormal move
-4.9%
Stock minus SPY
Volume
1.0×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
APOSPY benchmark
Ask FN2 about APO FY2026 Q3
Transcript, numbers and history already loaded
What drove APO's -4.4% move after FY2026 Q3 earnings?What changed in APO's guidance and outlook in FY2026 Q3?Give me the bull and bear case for APO after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management described record Q3 fee-related and spread-related earnings, a $114 billion origination pipeline and $53 billion of capital formation. It highlighted a strategic shift toward investment-grade credit and new liquidity, valuation and market-making capabilities for private assets.
Guidance delta
Management reaffirmed 2027 guidance for more than 20% FRE growth and approximately 10% SRE growth. The supplied analysis characterizes guidance as maintained.
Key takeaways
- Record Q3 FRE and SRE were supported by origination and capital formation, according to the supplied transcript analysis.
- The $114 billion origination pipeline was predominantly investment-grade debt (more than 80%), with activity spanning energy, infrastructure, sports and compute.
- Management plans to invest $350 million over 24 months in data, CUSIP, market-making and custody capabilities.
- Apollo is advancing AMAPS, ADL 3 and a European credit platform as it seeks to expand private-credit and liquidity offerings.
Management priorities
- Build data, CUSIP, market-making and custody infrastructure over 24 months.
- Expand AMAPS and develop its longer-term counterpart, APADS.
- Roll out the ADL 3 direct-lending program and develop a European investment-grade credit platform.
- Complete the pending minority investment in Mubadala Capital.
Follow APO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$113.55Current
$48Low
$118.88Average
$188High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 19, 2026 |
| UBS | Buy | Buy | Maintain | Oct 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 2, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 21, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Nov 5, 2025 |
| Citigroup | Buy | Buy | Maintain | Oct 13, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| B of A Securities | Buy | Buy | Maintain | May 5, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 11, 2024 |
| Argus Research | Buy | Buy | Maintain | Aug 20, 2024 |
| Jefferies | Hold | Hold | Maintain | May 9, 2024 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 9, 2023 |
| JMP Securities | Market Perform | Market Perform | Maintain | May 26, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 19, 2022 |
| CFRA | Buy | Buy | Maintain | Nov 25, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Feb 7, 2017 |
| Argus | Buy | Buy | Maintain | Aug 12, 2016 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Aug 4, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 3, 2015 |
| Bernstein | Outperform | Outperform | Maintain | Apr 3, 2014 |
| Sterne Agee | Buy | Buy | Maintain | Aug 6, 2013 |
| Compass Point | Buy | Buy | Maintain | Feb 13, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $113.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Daniel Welden | $127 | $114.34 | +11.8% | Oct 1, 2026 |
| HSBC | Analyst unavailable | $145 | $120.47 | +27.7% | Jul 20, 2026 |
| RBC Capital | Bart Dziarski | $142 | $113.73 | +25.1% | Feb 23, 2026 |
| Goldman Sachs | Alexander Bolstein | $165 | $135.88 | +45.3% | Feb 9, 2026 |
| UBS | Michael Brown | $186 | $149.06 | +63.8% | Dec 11, 2025 |
| BMO Capital | Brennan Hawken | $136 | $130.1 | +19.8% | Nov 25, 2025 |
| Goldman Sachs | Alexander Bolstein | $155 | $130.17 | +36.5% | Nov 25, 2025 |
| Piper Sandler | John Barnidge | $188 | $184.07 | +65.6% | Dec 9, 2024 |
| BMO Capital | Etinenne Ricard | $157 | $147.62 | +38.3% | Nov 6, 2024 |
| Wells Fargo | Michael Brown | $164 | $163.67 | +44.4% | Nov 6, 2024 |
| Evercore ISI | Glenn Schorr | $174 | $147.62 | +53.2% | Nov 6, 2024 |
| Deutsche Bank | Brian Bedell | $155 | $147.62 | +36.5% | Nov 6, 2024 |
| Goldman Sachs | Alexander Blostein | $135 | $131.54 | +18.9% | Oct 3, 2024 |
| Evercore ISI | Glenn Schorr | $150 | $132.01 | +32.1% | Oct 2, 2024 |
| Wells Fargo | Michael Brown | $148 | $132.01 | +30.3% | Oct 2, 2024 |
| Wolfe Research | Steven Chubak | $139 | $125.13 | +22.4% | Sep 24, 2024 |
| Wells Fargo | Michael Brown | $132 | $108.67 | +16.2% | Sep 11, 2024 |
| Citigroup | Chris Allen | $135 | $105.58 | +18.9% | Sep 11, 2024 |
| Argus Research | Stephen Biggar | $125 | $111.61 | +10.1% | Aug 20, 2024 |
| Bank of America Securities | Craig Siegenthaler | $123 | $105.04 | +8.3% | Aug 6, 2024 |
| Jefferies | Daniel Fannon | $117 | $113.32 | +3.0% | May 9, 2024 |
| Barclays | Benjamin Budish | $133 | $114.67 | +17.1% | Apr 8, 2024 |
| BMO Capital | Etinenne Ricard | $122 | $111.08 | +7.4% | Apr 5, 2024 |
| Deutsche Bank | Brian Bedell | $123 | $111.08 | +8.3% | Apr 5, 2024 |
| Loop Capital Markets | Rufus Hone | $103 | $91.26 | -9.3% | Sep 15, 2023 |
| Barclays | Analyst unavailable | $85 | $68.24 | -25.1% | Jan 12, 2023 |
| Wells Fargo | Analyst unavailable | $74 | $66.52 | -34.8% | Jan 11, 2023 |
| Barclays | Analyst unavailable | $78 | $62.51 | -31.3% | Dec 19, 2022 |
| Deutsche Bank | Analyst unavailable | $83 | $64.88 | -26.9% | Nov 15, 2022 |
| Deutsche Bank | Brian Bedell | $91 | $58.2 | -19.9% | Aug 23, 2022 |
| Morgan Stanley | Analyst unavailable | $61 | $60.59 | -46.3% | Aug 15, 2022 |
| Oppenheimer | Analyst unavailable | $61 | $57.53 | -46.3% | Aug 8, 2022 |
| Deutsche Bank | Analyst unavailable | $88 | $50.3 | -22.5% | Jul 13, 2022 |
| Wells Fargo | Analyst unavailable | $66 | $49.16 | -41.9% | Jul 13, 2022 |
| Deutsche Bank | Brian Bedell | $90 | $54.48 | -20.7% | May 22, 2022 |
| Citigroup | Ronald Josey | $50 | $60 | -56.0% | Apr 21, 2022 |
| Morgan Stanley | Analyst unavailable | $81 | $59.52 | -28.7% | Apr 20, 2022 |
| Rosenblatt Securities | Barton Crockett | $48 | $59.44 | -57.7% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $71 | $58.1 | -37.5% | Apr 19, 2022 |
| Citigroup | William Katz | $87.5 | $57.49 | -22.9% | Apr 16, 2022 |
| Deutsche Bank | Brian Bedell | $95 | $56.87 | -16.3% | Apr 11, 2022 |
| Morgan Stanley | Michael Cyprys | $88 | $61.58 | -22.5% | Mar 17, 2022 |
| BMO Capital | Rufus Hone | $100 | $67.58 | -11.9% | Feb 15, 2022 |
| Argus Research | Stephen Biggar | $90 | $75.34 | -20.7% | Nov 9, 2021 |
| Jefferies | Gerald O'Hara | $80 | $77 | -29.5% | Nov 3, 2021 |
Track every rating change on APO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationApollo Global Management, Inc. operates as a prominent investment management firm, primarily concentrating its efforts across credit, private equity, and real estate asset classes. Within its private equity division, Apollo engages in a broad spectrum of transactions, ranging from traditional management buyouts, recapitalizations, and distressed acquisitions to corporate carve-outs, growth capital infusions, turnaround financing, bridge loans, strategic acquisitions, and industry consolidation initiatives. This also includes debt investments in real estate and corporate partnerships, along with investments in distressed assets and special situations within the middle market. Its client base is diverse, encompassing sovereign wealth and endowment funds, as well as various other institutional and private investors. The firm constructs and oversees bespoke portfolios for clients and actively manages a suite of investment vehicles, including hedge funds, real estate funds, and private equity funds.…
Historical context
All APO earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| EQH-PA Equitable Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +14.5% | — | Equitable Holdings: EPS Growth, Corebridge Synergies in Focus |
| CRBG Corebridge Financial, Inc. | FY2026 Q3 · Calendar Q4 2026 | -0.8% | +2.5% | Corebridge’s operating earnings grew, while revenue fell short of consensus |
Latest beats and misses
Who reports nextBeat on EPS
- RRXFY2026 Q3 · November 3, 2026+41.1% EPS+11.8% move
- UDRFY2026 Q3 · November 2, 2026+340.8% EPS+0.1% move
- VNOMFY2026 Q3 · November 2, 2026+3.9% EPS-2.6% move
- EQH-PAFY2026 Q3 · November 2, 2026+14.5% EPS— move
- WMBFY2026 Q3 · November 2, 2026+0.2% EPS+3.5% move
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
Get the APO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T19:05:34.020530+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T19:30:48.060741+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T19:30:48.058217+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.